ACUTE CORONARY SYNDROMES
Clinical trials for ACUTE CORONARY SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new ACUTE CORONARY SYNDROMES trials appear
Sign up with your email to follow new studies for ACUTE CORONARY SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dissolvable stent could revolutionize heart disease treatment
Disease control Recruiting nowThis study tests a new type of heart stent that slowly dissolves over time. It is designed for people with long blockages in their coronary arteries. The goal is to see if the stent is safe and effective at keeping arteries open without needing a permanent metal implant.
Matched conditions: ACUTE CORONARY SYNDROMES
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated May 17, 2026 10:41 UTC
-
Herb power: oregano and basil may soothe unstable angina
Disease control Recruiting nowThis study looks at whether adding oregano and basil leaves to the diet can lower inflammation and improve cholesterol levels in people who have recently had unstable angina. About 70 participants will eat these herbs and have their blood and urine tested. The goal is to see if a…
Matched conditions: ACUTE CORONARY SYNDROMES
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated May 17, 2026 10:40 UTC
-
New drug aims to cool hidden heart inflammation after attack
Disease control Recruiting nowThis study tests a drug called orticumab in 240 people who had a heart attack and still have high inflammation in their heart arteries. The goal is to see if orticumab can lower that inflammation better than a placebo over 6 months, using special CT scans to measure changes. Part…
Matched conditions: ACUTE CORONARY SYNDROMES
Phase: PHASE2 • Sponsor: Abcentra • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New heart drug UDP-003 enters first human safety trials
Disease control Recruiting nowThis early-stage trial is testing whether a new drug called UDP-003 is safe for people. It involves 84 participants: healthy adults and patients who had a heart attack or unstable angina at least a year ago. The study gives single or multiple doses of the drug or a placebo and mo…
Matched conditions: ACUTE CORONARY SYNDROMES
Phase: EARLY_PHASE1 • Sponsor: Cyclarity Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New rapid heart attack test could slash ER wait times
Diagnosis Recruiting nowThis study tests a new, faster blood test for heart attacks in the emergency room. The goal is to see if using this quick test can safely rule out a heart attack and get patients discharged sooner than the current standard lab test. About 1,500 adults with chest pain will be rand…
Matched conditions: ACUTE CORONARY SYNDROMES
Phase: NA • Sponsor: KU Leuven • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC
-
Hand fan may stop Drug-Induced breathlessness in heart patients
Symptom relief Recruiting nowThis study tests whether using a hand fan can prevent or reduce shortness of breath caused by the heart drug ticagrelor. Researchers will enroll 110 adults with acute coronary syndrome who are starting ticagrelor for the first time. Participants will receive fan therapy, and the …
Matched conditions: ACUTE CORONARY SYNDROMES
Phase: NA • Sponsor: Acibadem University • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
New scanner could predict heart attack Patients' future risk
Knowledge-focused Recruiting nowThis study will test a new technology called Cor-IS that measures how well blood vessels widen (flow mediated dilation) in 100 people hospitalized for a heart attack. Researchers want to see if this method can better predict future heart problems compared to standard tests. Parti…
Matched conditions: ACUTE CORONARY SYNDROMES
Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC